Radiomic signatures of brain metastases on MRI: utility in predicting pathological subtypes of lung cancer

Le résumé fourni par la source

Background: The pathological sub-classification of lung cancer is crucial in diagnosis, treatment and prognosis for patients. Quick and timely identification of pathological subtypes from imaging examinations rather than histological tests could help guiding therapeutic strategies. The aim of the study is to construct a non-invasive radiomics-based model for predicting the subtypes of lung cancer on brain metastases (BMs) from multiple magnetic resonance imaging (MRI) sequences. Methods: One hundred and sixty-one patients of primary lung cancer with synchronous BMs [121 with adenocarcinoma (AD); 40 with small cell lung carcinoma (SCLC)] were enrolled in the study (129 and 32 in the training set and validation set). A total of 960 radiomics features were extracted from multiple MRI sequences [fluid attenuated inversion recovery (FLAIR), diffusion weighted imaging (DWI), contrast-enhanced T1 weighted imaging (CE-T1WI) and contrast-enhanced susceptibility weighted imaging (CE-SWI)] and four clinical features were recorded. Forty-one key features were selected by the least absolute shrinkage selection operator (LASSO). The machine learning (ML) models for predicting AD and SCLC with radiomics features alone and with radiomics features plus clinical features were constructed using classifiers of logistic regression (LR), random forest (RF), support vector machine (SVM) and extreme gradient boosting (XGBoost). The prediction performance of models was evaluated by accuracy (ACC), sensitivity (SEN), specificity (SPE), F1 score and area under the curves (AUC). Results: 0.8750, respectively, when using radiomics features alone and radiomics features plus clinical features. In the best-performing model using XGBoost, combination of conventional MRI sequences and CE-SWI had better sub-classification performance than conventional MRI sequences. Conclusions: Radiomics of BMs from multiple MRI sequences provides high discriminatory performance in predicting AD and SCLC using classifiers of LR, RF and XGBoost, and can serve as a potential useful tool to non-invasively distinguish pathological subtypes of lung cancer.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.